Clinical Trial Update: Clinical and Technical Feasibility of a Ultrasuperparamagnetic Nanoparticle Iron Oxide (USPIO)-Enhanced Magnetic Resonance Lymph Node Imaging [NA]

View source ↗

Summary

Completed clinical trial evaluating the feasibility of USPIO-enhanced MRI for lymph node imaging in cancer of the lymph node; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer of Lymph Node

Drugs mentioned

• Ultrasuperparamagnetic nanoparticle iron oxide (USPIO)-enhanced MRI (USPIO-enhanced MRI)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Cancer of Lymph Node | NA | Status: COMPLETED | Results posted: 2020-10-19